XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Sep. 30, 2023
Current    
Cash and cash equivalents $ 143,765 $ 151,024
Incentive and tax receivables 3,549 2,709
Prepaid expenses and other current assets 756 653
Total Assets 148,070 154,386
Current Liabilities    
Accounts payable 4,292 4,322
Accrued liabilities - Note 4 7,286 7,295
Deferred grant income - Note 3 917 917
Total Liabilities 12,495 12,534
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 82,086,511 common shares (September 30, 2023 - 82,066,511) 82 82
Additional paid-in capital 437,184 434,839
Accumulated deficit (301,691) (293,069)
Total Stockholders' Equity 135,575 141,852
 Total Liabilities and Stockholders' Equity $ 148,070 $ 154,386